KPIs & Operating Metrics(New)
Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Markel (MKL) Cash & Equivalents (2016 - 2025)

Markel (MKL) has disclosed Cash & Equivalents for 17 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 7.37% to $4.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, up 7.37% year-over-year, with the annual reading at $4.0 billion for FY2025, 7.37% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $4.0 billion at Markel, down from $4.0 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $4.4 billion in Q3 2023, with the low at $3.5 billion in Q2 2024.
  • Average Cash & Equivalents over 5 years is $3.9 billion, with a median of $3.9 billion recorded in 2021.
  • The sharpest move saw Cash & Equivalents dropped 23.88% in 2021, then grew 22.99% in 2023.
  • Over 5 years, Cash & Equivalents stood at $4.0 billion in 2021, then rose by 4.0% to $4.1 billion in 2022, then dropped by 9.44% to $3.7 billion in 2023, then decreased by 1.45% to $3.7 billion in 2024, then rose by 7.37% to $4.0 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $4.0 billion, $4.0 billion, and $3.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.